Halozyme Therapeutics, Inc. (BMV:HALO)
Mexico flag Mexico · Delayed Price · Currency is MXN
1,121.86
+103.35 (10.15%)
At close: Jul 29, 2025

Halozyme Therapeutics Revenue

Halozyme Therapeutics had revenue of $325.72M USD in the quarter ending June 30, 2025, with 40.79% growth. This brings the company's revenue in the last twelve months to $1.18B, up 34.97% year-over-year. In the year 2024, Halozyme Therapeutics had annual revenue of $1.02B with 22.44% growth.

Revenue (ttm)
$1.18B
Revenue Growth
+34.97%
P/S Ratio
6.26
Revenue / Employee
$3.37M
Employees
350
Market Cap
139.05B MXN

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.02B186.07M22.44%
Dec 31, 2023829.25M169.14M25.62%
Dec 31, 2022660.12M216.81M48.91%
Dec 31, 2021443.31M175.72M65.67%
Dec 31, 2020267.59M71.60M36.53%
Dec 31, 2019195.99M44.13M29.06%
Dec 31, 2018151.86M-164.75M-52.04%
Dec 31, 2017316.61M169.92M115.84%
Dec 31, 2016146.69M11.63M8.61%
Dec 31, 2015135.06M59.72M79.28%
Dec 31, 201475.33M20.54M37.47%
Dec 31, 201354.80M12.47M29.47%
Dec 31, 201242.33M-13.76M-24.54%
Dec 31, 201156.09M42.46M311.67%
Dec 31, 201013.62M-47.19K-0.35%
Dec 31, 200913.67M4.91M55.99%
Dec 31, 20088.76M4.96M130.66%
Dec 31, 20073.80M2.82M287.02%
Dec 31, 2006981.75K854.54K671.76%
Dec 31, 2005127.21K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition